当前位置:首页 - 行情中心 - 双鹭药业(002038) - 财务分析 - 资产负债表

双鹭药业

(002038)

  

流通市值:74.50亿  总市值:89.89亿
流通股本:8.51亿   总股本:10.27亿

资产负债表

报告期2023-09-302023-06-302023-03-312022-12-31
公司类型通用通用通用通用
流动资产:
货币资金735,397,510.2704,901,879.94702,888,229.93595,037,834.97
应收票据及应收账款188,151,075.84198,763,001.1225,419,317.11252,569,923.49
应收账款188,151,075.84198,763,001.1225,419,317.11252,569,923.49
应收款项融资3,623,908.098,016,366.816,790,433.592,288,095.33
预付款项114,998,065.6121,141,856.38136,533,387.32120,202,272.82
其他应收款合计17,067,447.3817,502,600.8431,586,963.3631,346,196.49
应收股利--14,695,536.4614,695,536.46
存货149,611,885.77159,878,991.55184,668,862.51136,817,985.18
其他流动资产702,777,831.03689,463,907.72684,306,695.47714,505,335.02
流动资产平衡项目0000
流动资产合计2,048,072,703.912,039,044,474.342,113,468,466.291,997,673,975.3
非流动资产:
长期股权投资899,759,771.71902,609,619.54895,567,812.31897,124,263.03
其他非流动金融资产629,219,312.05656,573,547.8649,011,317.43542,930,721.44
投资性房地产14,308,564.8914,534,996.6414,761,428.3914,987,860.14
固定资产439,138,997.51449,875,930.8458,425,281.13462,556,151.57
在建工程60,095,920.3160,060,040.3159,957,600.5864,748,010.44
无形资产643,070,324.17587,721,715.89572,789,237.82526,361,667.29
开发支出434,237,048.1481,450,717.45421,887,438.24452,144,907.15
长期待摊费用2,191,111.142,191,111.142,276,581.222,276,581.22
递延所得税资产39,751,901.2137,942,608.9427,347,659.9539,498,135.75
其他非流动资产857,764,713.99854,822,572.31873,681,688.15875,537,596.41
非流动资产平衡项目0000
非流动资产合计4,019,537,665.084,047,782,860.823,975,706,045.223,878,165,894.44
资产平衡项目0000
资产总计6,067,610,368.996,086,827,335.166,089,174,511.515,875,839,869.74
流动负债:
应付票据及应付账款168,241,803.39176,290,106.03173,179,452.52176,179,335.46
应付账款168,241,803.39176,290,106.03173,179,452.52176,179,335.46
预收款项1,827,538.68611,7001,086,800626,666.66
合同负债11,138,500.7515,287,389.7217,246,563.5827,246,608.12
应付职工薪酬27,882,088.5126,570,958.5626,222,54724,079,319.96
应交税费3,445,694.87,190,216.4916,656,435.858,982,889.73
其他应付款合计48,006,589.2550,110,353.754,846,693.6750,234,096.73
其他流动负债472,952.34634,934.36675,092.451,482,303.54
流动负债平衡项目0000
流动负债合计261,015,167.72276,695,658.86289,913,585.07288,831,220.2
非流动负债:
递延收益47,210,076.1747,210,076.1747,210,076.1751,379,225.68
递延所得税负债66,654,246.1270,239,059.0269,404,100.6556,391,215.59
非流动负债平衡项目0000
非流动负债合计113,864,322.29117,449,135.19116,614,176.82107,770,441.27
负债平衡项目0000
负债合计374,879,490.01394,144,794.05406,527,761.89396,601,661.47
所有者权益(或股东权益):
实收资本(或股本)1,027,350,0001,027,350,0001,027,350,0001,027,350,000
资本公积43,846,655.8643,846,655.8643,846,655.8643,846,655.86
其他综合收益666,996.65666,996.65666,996.65666,996.65
盈余公积632,410,430.74632,410,430.74632,410,430.74632,410,430.74
未分配利润3,978,641,325.313,978,237,370.683,965,737,951.233,763,808,244.41
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计5,682,915,408.565,682,511,453.935,670,012,034.485,468,082,327.66
少数股东权益9,815,470.4210,171,087.1812,634,715.1411,155,880.61
股东权益平衡项目0000
股东权益合计5,692,730,878.985,692,682,541.115,682,646,749.625,479,238,208.27
负债和股东权益合计6,067,610,368.996,086,827,335.166,089,174,511.515,875,839,869.74
公告日期2023-10-262023-08-252023-04-262023-04-26
审计意见(境内)标准无保留意见
TOP↑